Change Agent: One Leader’s Proven Formula to Dramatically Improve Finance and GBS Operations
Call Nigel Coffey a change agent, or call him a serial innovator. Everywhere Nigel takes on a new leadership challenge, he executes a program that adds tangible bottom-line value to his new organization. Starting with industry benchmarking, following with an audit of payments to suppliers to identify root cause issues and control weaknesses, and progressing through a systematic program of automation, Nigel has succeeded time and time again in moving each company to world-class procure-to-pay processes and technologies.
In his career Nigel has held senior business service, finance and transformation roles at Pfizer, PepsiCo, Shire Pharmaceuticals/Takeda and now Alnylam Pharmaceuticals. As the Head of Finance operations at this rapidly-growing biotech, he's helping optimize the processes to help this compnay produce leading-edge therapies based on the latest RNA interference science.
This December 7, Nigel and Danny Thompson, SVP of Market & Product Strategy at apexanalytix, as they discuss:
- How fresh industry benchmarking information on finance and procure-to-pay best practices can be leveraged to establish goals and inform business cases for talent and technology.
- The one-two punch of recovery audit: improving AP profitability and uncovering weak controls, supplier issues and root causes of overpayments.
- Optimising prior to automating: why improving and rationalising end-to-end processes, policies, procedures and controls is critical before selecting and implementing technology.
Featuring: the latest 2021 benchmarking results from apexanalytix’s P2PKey Practices Benchmarking survey. The newest P2P survey data and insights from top tier global companies.
Speakers
Nigel Coffey
Head of Finance Operations
Alnylam Pharmaceuticals
Global shared/business services and finance transformation executive with extensive experience in exceptionally large dynamic global organizations Has previously held Finance Director and shared service leadership roles in Novo Nordisk, Pfizer, Pepsico and Shire which was recently acquired by Takeda. Nigel is currently in between roles and enjoying spending quality lockdown time with his family He is a qualified Chartered Accountant and also worked with Arthur Andersen and Price Waterhouse in their audit functions.
Danny Thompson
SVP, Market & Product Strategy
apexanalytix
As senior vice president of market and product strategy at APEX Analytix, Danny Thompson is responsible for defining, communicating and leading our company’s software product strategy and roadmap. He works closely with our customers to ensure that each solution helps them meet their business objectives. Danny has a proven track record in the procure-to-pay arena, with a strong background in ERP implementation, process automation and financial shared services. He previously was vice president of product management at Tungsten Network, a global business-to-business e-invoicing firm. He also is a former global process driver for invoice-to-pay at Pfizer. Danny earned a B.A. degree from Harding University.
Sponsor
